Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 7

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Amiante et pathologie respiratoire

Scherpereel, Arnaud · 2016 · La Presse Médicale

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.lpm.2015.12.011

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 45

  1. Scherpereel, 2006, La conférence d’experts de la Société de pneumologie de langue française (SPLF) sur le mésothéliome pleural malin (MPM) : des recommandations utiles et nécessaires, Rev Mal Respir, 23, 5, 10.1016/S0761-8425(06)71779-X · doi:10.1016/s0761-8425(06)71779-x
  2. Moitra, 2015, Global perspectives of emerging occupational and environmental lung diseases, Curr Opin Pulm Med, 21, 114, 10.1097/MCP.0000000000000136 · DOI
  3. Bayram, 2014, Environmental exposure to asbestos: from geology to mesothelioma, Curr Opin Pulm Med, 20, 301, 10.1097/MCP.0000000000000053 · DOI
  4. Liu, 2013, Molecular basis of asbestos-induced lung disease, Annu Rev Pathol, 8, 161, 10.1146/annurev-pathol-020712-163942 · DOI · Paper page
  5. Nishimura, 2015, Functional alteration of natural killer cells and cytotoxic T lymphocytes upon asbestos exposure and in malignant mesothelioma patients, Biomed Res Int, 238431
  6. Valeyre, 1999, Asbestose, Rev Mal Respir, 16, 1294
  7. Norbet, 2015, Asbestos-related lung disease: a pictorial review, Curr Probl Diagn Radiol, 44, 371, 10.1067/j.cpradiol.2014.10.002 · DOI
  8. Astoul, 2012, Malignant pleural mesothelioma: from the bench to the bedside, Respiration, 83, 481, 10.1159/000339259 · DOI
  9. Pairon, 2015, Éditorial. Amiante et effets sur la santé : une thématique toujours d’actualité, Bull Epidemiol Hebd, 26
  10. Stayner, 2013, The worldwide pandemic of asbestos-related diseases, Annu Rev Public Health, 34, 205, 10.1146/annurev-publhealth-031811-124704 · DOI · Paper page
  11. Pairon, 2013, Pleural plaques and the risk of pleural mesothelioma, J Natl Cancer Inst, 105, 293, 10.1093/jnci/djs513 · DOI
  12. Berry, 2012, Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up, Br J Cancer, 106, 1016, 10.1038/bjc.2012.23 · doi:10.1038/bjc.2012.23
  13. Markowitz, 2013, Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort, Am J Respir Crit Care Med, 188, 90, 10.1164/rccm.201302-0257OC · DOI · Paper page
  14. Kopylev, 2015, A systematic review of the association between pleural plaques and changes in lung function, Occup Environ Med, 72, 606, 10.1136/oemed-2014-102468 · DOI
  15. Banks, 2009, American College of Chest Physicians consensus statement on the respiratory health effects of asbestos. Results of a Delphi study, Chest, 135, 1619, 10.1378/chest.08-1345 · DOI
  16. Wilken, 2011, Lung function in asbestos-exposed workers, a systematic review and meta-analysis, J Occup Med Toxicol, 6, 21, 10.1186/1745-6673-6-21 · DOI
  17. Pairon, 2014, Asbestos exposure, pleural plaques, and the risk of death from lung cancer, Am J Respir Crit Care Med, 190, 1413, 10.1164/rccm.201406-1074OC · DOI
  18. Churg, 2015, New markers for separating benign from malignant mesothelial proliferations: are we there yet?, Arch Pathol Lab Med
  19. Rodriguez-Panadero, 2006, Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion, Eur Respir J, 28, 409, 10.1183/09031936.06.00013706 · doi:10.1183/09031936.06.00013706
  20. Gilg Soit Ilg, 2015, Programme national de surveillance du mésothéliome (PNSM). Actualisation des principaux résultats, Bull Epidemiol Hebd, 28
  21. Chamming's, 2013, Compensation of pleural mesothelioma in France: data from the French National Mesothelioma Surveillance Programme, Am J Ind Med, 56, 146, 10.1002/ajim.22106 · doi:10.1002/ajim.22106
  22. Nielsen, 2014, Occupational asbestos exposure and lung cancer – a systematic review of the literature, Arch Environ Occup Health, 69, 191, 10.1080/19338244.2013.863752 · DOI · Paper page
  23. van der Bij, 2013, Lung cancer risk at low cumulative asbestos exposure: meta-regression of the exposure-response relationship, Cancer Causes Control, 24, 1, 10.1007/s10552-012-0107-7 · DOI · Paper page
  24. Debieuvre, 2014, Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians, Rev Mal Respir, 31, 805, 10.1016/j.rmr.2013.10.644 · doi:10.1016/j.rmr.2013.10.644
  25. Borghaei, 2015, Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N Engl J Med, 373, 1627, 10.1056/NEJMoa1507643 · DOI · Paper page
  26. Aberle, 2011, Reduced lung cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 · DOI · Paper page
  27. Ilie, 2014, “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease, PLoS One, 9, e111597, 10.1371/journal.pone.0111597 · DOI · Paper page
  28. Lamote, 2014, Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesis, Cancer Epidemiol Biomarkers Prev, 23, 898, 10.1158/1055-9965.EPI-13-0737 · DOI
  29. Ollier, 2014, Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis, Chest, 145, 1339, 10.1378/chest.13-2181 · DOI
  30. Nasu, 2015, High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma, J Thorac Oncol, 10, 565, 10.1097/JTO.0000000000000471 · DOI · Paper page
  31. Le Stang, 2010, Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005, Int J Cancer, 126, 232, 10.1002/ijc.24711 · DOI
  32. Gallot, 2015, Déclaration obligatoire des mésothéliomes en France : principaux résultats, 2012–2013, Bull Epidemiol Hebd, 47
  33. Scherpereel, 2010, Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma, Eur Respir J, 35, 479, 10.1183/09031936.00063109 · DOI · Paper page
  34. van Zandwijk, 2013, Guidelines for the diagnosis and treatment of malignant pleural mesothelioma, J Thorac Dis, 5, E254
  35. Travis, 2015, Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart, J Thorac Oncol, 10, 1240, 10.1097/JTO.0000000000000663 · DOI · Paper page
  36. Zalcman, 2015, Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial, Lancet
  37. Delourme, 2013, Malignant pleural mesothelioma: diagnosis and treatment, Rev Pneumol Clin, 69, 26, 10.1016/j.pneumo.2012.12.003 · doi:10.1016/j.pneumo.2012.12.003
  38. Scherpereel, 2015, Mésothéliome pleural malin : état des lieux, La Lettre du Cancérologue, 1
  39. Garon, 2015, Pembrolizumab for the treatment of non-small-cell lung cancer, N Engl J Med, 372, 2018, 10.1056/NEJMoa1501824 · DOI · Paper page
  40. Brahmer, 2015, Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer, N Engl J Med, 373, 123, 10.1056/NEJMoa1504627 · DOI · Paper page
  41. Robinson, 2003, Mesothelin-family proteins and diagnosis of mesothelioma, Lancet, 362, 1612, 10.1016/S0140-6736(03)14794-0 · DOI · Paper page
  42. Scherpereel, 2006, Soluble mesothelin-related protein in the diagnosis of malignant pleural mesothelioma, Am J Respir Crit Care Med, 173, 1155, 10.1164/rccm.200511-1789OC · DOI · Paper page
  43. Pass, 2005, Asbestos exposure, pleural mesothelioma, and serum osteopontin levels, N Engl J Med, 353, 1564, 10.1056/NEJMoa051185 · DOI · Paper page
  44. Marchand, 2000, Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: results of a case-control study, Am J Ind Med, 37, 581, 10.1002/(SICI)1097-0274(200006)37:6<581::AID-AJIM2>3.0.CO;2-D · doi:10.1002/(sici)1097-0274(200006)37:6<581::aid-ajim2>3.0.co;2-d
  45. Kang, 1997, Gastrointestinal cancer mortality of workers in occupations with high asbestos exposures, Am J Ind Med, 31, 713, 10.1002/(SICI)1097-0274(199706)31:6<713::AID-AJIM7>3.0.CO;2-R · doi:10.1002/(sici)1097-0274(199706)31:6<713::aid-ajim7>3.0.co;2-r

Metadata

Authors
Scherpereel, A.
Venue
La Presse Médicale
Publisher
Elsevier BV
Published
2016-01
Volume
45
Issue
1
Pages
117-132
ISSN
0755-4982
Cited by
7
References
1
Language
fr
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amiante et pathologie respiratoire. https://app.cochat.ai/papers/10.1016/j.lpm.2015.12.011
The paper
Scherpereel, A. (2016). Amiante et pathologie respiratoire. La Presse Médicale. https://doi.org/10.1016/j.lpm.2015.12.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.